Inflammatory Diseases Market

Inflammatory Diseases Market: Global Industry Analysis and Opportunity Assessment 2017-2027

  • Ongoing
  • January 2020
  • REP-GB-2723
  • PDF PPT EXCEL
Inflammatory Diseases Market
  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This Inflammatory Diseases market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Inflammatory Diseases market.


A new understanding of inflammatory diseases has changed the drug development landscape for several major diseases that are affecting millions of people in the world. Inflammation describes the primary response of the body that eliminates the cause of injury. Periodically, body’s defense mechanism works inappropriately that leads to inflammation. Drug development has focused on treating each disease symptoms separately. The discovery of drugs to treat inflammatory diseases related with immune system is driving the market towards growth. Immune Mediated Inflammatory diseases represent a global threat in terms of quality of life, morbidity and mortality that leads to increasing opportunity to develop new treatments to conquer the inflammatory diseases and increase market share. On the top inflammatory diseases are most common in human beings. Increasing popularity of inflammatory diseases and treatment followed by anti-inflammatory drugs with lesser side effects is driving the global inflammatory diseases market.

Based on type of diseases, global inflammatory diseases market can be segmented into following

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Need granular data and specific insights that are hard to get?
>
  • Heart disease

  • Multiple Sclerosis

  • Psoriasis

  • Inflammatory Bowel Disease

  • Others

  • On the basis of type of disease global inflammatory diseases market is segmented into respiratory diseases, heart disease, multiple sclerosis, Psoriasis, inflammatory bowel disease, bone disease and others. Respiratory diseases are further classified into asthma and chronic obstructive pulmonary disease, where asthma is a condition in that a person’s airways become swollen, narrow and inflamed to produce extra mucus and chronic obstructive pulmonary disease (COPD) is name for a group of lung conditions that causes due to smoking in adults that leads to breathing difficulties. Heart disease or heart disorders are conditions in that heart stops functioning, there are several types of heart diseases like arrhythmias heart disease, atherosclerotic and cardiomyopathy. Multiple sclerosis is a degenerative disease that attack central nervous system and disrupts the flow of information within the brain. Psoriasis is systemic inflammation that causes red and flaky plaques with joint pain of psoriatic arthritis. Inflammatory bowel disease involves inflammation related with gastro intestinal tract, includes to most common diseases of gastro intestinal tract that are crohn’s disease and ulcerative disease. Bone disease mostly includes rheumatoid arthritis and osteoarthritis.

    Moreover, on the basis of drug class used in treatment of inflammatory diseases global inflammatory diseases market is segmented into non-steroidal anti-inflammatory drugs, anti-inflammatory biologics and corticosteroids. Non-steroidal anti-inflammatory drugs bound the production of hormones in the body such as prostaglandins that is responsible for inflammation. Anti-inflammatory biologics are mostly used in treatment of arthritis indications in rheumatoid arthritis and osteoarthritis that is one of the revenue generating segment followed by respiratory diseases like asthma and chronic obstructive pulmonary disease. On the basis of distribution channel global inflammatory disease market is segmented into hospital pharmacy, retail pharmacy, drug stores and online pharmacy.

    Geographically, global inflammatory market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific and Middle East Africa. North Amrica is dominating in inflammatory diseases market as there is demand for branded medicines over the generic medicines. Rising geriatric population is driving the inflammatory diseases market throughout the globe. Followed by North America, Asia Pacific and Latin America has shown increasing market share in inflammatory diseases.

    Some of the major players in global inflammatory diseases market are AstraZeneca, Merck & Co., GlaxoSmithKline, Bristol-Myers Squibb, F-Hoffmann-La-Roche, Eli Lilly and Sanofi. Other emerging competitors like Enlivex Therapeutics Ltd., Gilead Sciences, Immune Pharmaceuticals, Merck, Mitsubishi Tanabe Pharma Corporation, Neovacs, Prometheus Laboratories, Sandoz, and Takeda Pharmaceuticals are developing drug pipeline and launch of new products as key strategies.

    NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

    Unique Requirements? Customize this Report

    • Customize by Region, Country, Application, Product, & other segments
    • Integrate our Insights with your Existing Data
    • Determine the scope of the study to suit your requirements

    Let FMI Help You!

    • Gain Insights on Key Inflammatory Diseases Market Impacting Forces
    • Know the Winning Strategies of Market Leaders
    • Get Deep-Dive Analysis on Each Segment
    • Identify the Sources that will Drive Top-Line Revenue

    Based on type of drug class, global inflammatory diseases market can be segmented into following

    • Anti-inflammatory Biologics
    • Non-steroidal Anti-Inflammatory Drugs
    • Corticosteroids
    • Others

    Based on type of distribution channel, global inflammatory diseases market can be segmented into following

    • Hospital pharmacy
    • Retail pharmacy
    • Drug stores
    • Online pharmacy

    The report covers exhaustive analysis on:

    • Inflammatory Diseases  Market Segments
    • Inflammatory Diseases  Market Dynamics
    • Historical Actual Market Size, 2013 - 2015
    • Inflammatory Diseases  Market Size & Forecast 2017 to 2027
    • Inflammatory Diseases  Market Current Trends/Issues/Challenges
    • Competition & Companies involved
    • Inflammatory Diseases  Market Drivers and Restraints

    Regional analysis includes

    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East & Africa

    Report Highlights:

    • Detailed overview of parent market
    • Changing market dynamics of the industry
    • In-depth market segmentation
    • Historical, current and projected market size in terms of volume and value
    • Recent industry trends and developments
    • Competitive landscape
    • Strategies of key players and product offerings
    • Potential and niche segments/regions exhibiting promising growth
    • A neutral perspective towards market performance
    • Must-have information for market players to sustain and enhance their market footprint
    Get in touch
    Harish Tiwari

    Harish Tiwari

    Global Head - Business Development

    Pranay Mhaisekar

    Pranay Mhaisekar

    Business Development

    * indicates mandatory fields
    Our Clients

    Request Sample Request customization Request Methodology